Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000669222 | SCV000793953 | likely pathogenic | Congenital lipoid adrenal hyperplasia due to STAR deficency | 2017-09-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001388089 | SCV001588936 | pathogenic | not provided | 2024-02-16 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln77*) in the STAR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in STAR are known to be pathogenic (PMID: 8948562). This variant is present in population databases (rs781281145, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with congenital lipoid adrenal hyperplasia (PMID: 15347444, 30400872). ClinVar contains an entry for this variant (Variation ID: 553713). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV000669222 | SCV002786034 | pathogenic | Congenital lipoid adrenal hyperplasia due to STAR deficency | 2022-04-19 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000669222 | SCV002083264 | pathogenic | Congenital lipoid adrenal hyperplasia due to STAR deficency | 2020-07-18 | no assertion criteria provided | clinical testing |